Indivior PLC (NASDAQ:INDV) Given Consensus Rating of “Buy” by Analysts

Shares of Indivior PLC (NASDAQ:INDV) have received an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $19.60.

INDV has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Indivior from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 21st. HC Wainwright started coverage on shares of Indivior in a research note on Wednesday, August 6th. They set a “buy” rating and a $27.00 target price on the stock. Craig Hallum lifted their price target on shares of Indivior from $15.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, June 30th. Finally, Jefferies Financial Group initiated coverage on shares of Indivior in a report on Tuesday, July 22nd. They set a “buy” rating and a $20.00 price target on the stock.

Institutional Investors Weigh In On Indivior

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Two Seas Capital LP increased its stake in Indivior by 0.4% in the second quarter. Two Seas Capital LP now owns 11,407,795 shares of the company’s stock valued at $168,151,000 after purchasing an additional 41,018 shares in the last quarter. Deerfield Management Company L.P. Series C grew its position in Indivior by 74.4% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 8,883,160 shares of the company’s stock worth $110,418,000 after purchasing an additional 3,790,518 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Indivior by 18.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 8,368,996 shares of the company’s stock worth $79,757,000 after purchasing an additional 1,299,425 shares in the last quarter. Rubric Capital Management LP grew its position in Indivior by 31.6% in the 2nd quarter. Rubric Capital Management LP now owns 4,647,179 shares of the company’s stock worth $68,499,000 after purchasing an additional 1,117,140 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Indivior by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 4,631,221 shares of the company’s stock worth $43,765,000 after purchasing an additional 71,539 shares in the last quarter. 60.33% of the stock is owned by institutional investors.

Indivior Stock Up 1.3%

Shares of INDV opened at $23.46 on Friday. Indivior has a 12 month low of $7.33 and a 12 month high of $23.55. The firm’s 50 day moving average is $16.79 and its 200-day moving average is $12.62.

Indivior (NASDAQ:INDV) last announced its earnings results on Thursday, July 31st. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.26 by $0.25. The company had revenue of $302.00 million for the quarter, compared to analysts’ expectations of $239.43 million. Indivior had a net margin of 6.65% and a negative return on equity of 86.28%. As a group, research analysts anticipate that Indivior will post 1.22 earnings per share for the current fiscal year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.